Page 2185 - Williams Hematology ( PDFDrive )

2160 Part XII: Hemostasis and Thrombosis Chapter 125: Hereditary Fibrinogen Abnormalities 2161

10. de Maat M, Verschuur M: Fibrinogen heterogeneity: Inherited and noninherited. Curr 43. Casini A, Lukowski S, Quintard VL, et al: FGB mutations leading to congenital quan-
Opin Hematol 12:377, 2005. titative fibrinogen deficiencies: An update and report of four novel mutations. Thromb
11. Huang S, Mulvihill ER, Farrell DH, et al: Biosynthesis of human fibrinogen. Subunit Res 133:868, 2014.
interactions and potential intermediates in the assembly. J Biol Chem 268:8919, 1993. 44. Homer VM, Brennan SO, Ockelford P, George PM: Novel fibrinogen truncation with
12. Henschen-Edman AH: On the identification of beneficial and detrimental molecular deletion of Bbeta chain residues 440–461 causes hypofibrinogenaemia. Thromb Haemost
forms of fibrinogen. Haemostasis 29:179, 1999. 88:427, 2002.
13. Collen D, Tytgat GN, Claeys H, Piessens R: Metabolism and distribution of fibrinogen 45. Neerman-Arbez M, Vu D, Abu-Libdeh B, et al: Prenatal diagnosis for congenital afi-
I. Br J Haematol 22:681, 1972. brinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian
14. Handagama P, Scarborough RM, Shuman MA, Bainton DF: Endocytosis of fibrinogen family. Blood 101:3492, 2003.
into megakaryocytes and platelet alpha-granules is mediated by alpha IIb beta 3 (glyco- 46. Vu D, Di Sanza C, Caille D, et al: Quality control of fibrinogen secretion in the molecu-
protein IIb-IIIa). Blood 82:135, 1993. lar pathogenesis of congenital afibrinogenemia. Hum Mol Genet 14:3271, 2005.
15. Francis CW, Nachman RL, Marder VJ: Plasma and platelet fibrinogen differ in gamma 47. Duga S, Asselta R, Santagostino E, et al: Missense mutations in the human beta fibrin-
chain content. Thromb Haemost 51:84, 1984. ogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood
16. Weisel JW, Litvinov RI: Mechanisms of fibrin polymerization and clinical implications. 95:1336, 2000.
Blood 121:1712, 2013. 48. Vu D, Bolton-Maggs PH, Parr JR, et al: Congenital afibrinogenemia: Identification
17. Ariëns RA: Fibrin(ogen) and thrombotic disease. J Thromb Haemost 11 Suppl 1:294, and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood
2013. 102:4413, 2003.
18. Mosesson MW: The structure and biological features of fibrinogen and fibrin. Ann N Y 49. Spena S, Asselta R, Duga S, et al: Congenital afibrinogenemia: Intracellular retention of
Acad Sci 936:11, 2001. fibrinogen due to a novel W437G mutation in the fibrinogen Bbeta-chain gene. Biochim
19. Mosesson MW, DiOrio JP, Siebenlist KR, et al: Evidence for a second type of fibril Biophys Acta 1639:87, 2003.
branch point in fibrin polymer networks, the trimolecular junction. Blood 82:1517, 50. Monaldini L, Asselta R, Duga S, et al: Fibrinogen Mumbai: Intracellular retention due
1993. to a novel G434D mutation in the Bbeta-chain gene. Haematologica 91:628, 2006.
20. Lord ST: Fibrinogen and fibrin: Scaffold proteins in hemostasis. Curr Opin Hematol 51. Terasawa F, Okumura N, Kitano K, et al: Hypofibrinogenemia associated with a hete-
14:236, 2007. rozygous missense mutation gamma153Cys to Arg (Matsumoto IV): In vitro expression
21. Medved LV, Litvinovich SV, Ugarova TP, et al: Localization of a fibrin polymerization demonstrates defective secretion of the variant fibrinogen. Blood 94:4122, 1999.
site complimentary to Gly-His-Arg sequence. FEBS Lett 320:239, 1993. 52. Vu D, de Moerloose P, Batorova A, et al: Hypofibrinogenaemia caused by a novel FGG
22. Yang Z, Mochalkin I, Doolittle RF: A model of fibrin formation based on crystal struc- missense mutation (W253C) in the gamma chain globular domain impairing fibrino-
tures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl gen secretion. J Med Genet 42:e57, 2005.
Acad Sci U S A 97:14156, 2000. 53. Brennan SO, Wyatt J, Medicina D, et al: Fibrinogen Brescia: Hepatic endoplasmic retic-
23. Weisel JW, Medved LV: The structure and function of the alpha C domains of fibrino- ulum storage and hypofibrinogenemia because of a gamma284 Gly→Arg mutation. Am
gen. Ann N Y Acad Sci 936:312, 2001. J Pathol 157:189, 2000.
24. Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS: The covalent structure of factor 54. Brennan SO, Maghzal G, Shneider BL, et al: Novel fibrinogen gamma375 Arg→Trp
XIIIa crosslinked fibrinogen fibrils. J Struct Biol 115:88, 1995. mutation (fibrinogen Aguadilla) causes hepatic endoplasmic reticulum storage and
25. Siebenlist KR, Meh D, Mosesson MW: Protransglutaminase (factor XIII) mediated hypofibrinogenemia. Hepatology 36:652, 2002.
crosslinking of fibrinogen and fibrin. Thromb Haemost 86:1221, 2001. 55. Brennan SO, Davis RL, Conard K, et al: Novel fibrinogen mutation γ314Thr→Pro
26. Mosesson MW, Siebenlist KR, Hernandez I, et al: Evidence that alpha2-antiplasmin (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofi-
becomes covalently ligated to plasma fibrinogen in the circulation: A new role for brinogenaemia. Liver Int 30:1541, 2010.
plasma factor XIII in fibrinolysis regulation. J Thromb Haemost 6:1565, 2008. 56. Dib N, Quelin F, Ternisien C, et al: Fibrinogen Angers with a new deletion gamma
27. Smith KA, Pease RJ, Avery CA, et al: The activation peptide cleft exposed by thrombin GVYYQ 346–350 causes hypofibrinogenemia with hepatic storage. J Thromb Haemost
cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain. Blood 5:1999, 2007.
121:2117, 2013. 57. Peyvandi F, Kaufman RJ, Seligsohn U, et al: Rare bleeding disorders. Haemophilia
28. Makogonenko E, Ingham KC, Medved L: Interaction of the fibronectin COOH-termi- 12(Suppl 3):137, 2006.
nal Fib-2 regions with fibrin: Further characterization and localization of the Fib-2- 58. Van Meegeren ME, de Rooy JW, Schreuder HW, Brons PP: Bone cysts in patients with
binding sites. Biochemistry 46:5418, 2006. afibrinogenaemia: a literature review and two new cases. Haemophilia 20:244, 2014.
29. Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W: Evaluation of the fac- 59. Iwaki T, Sandoval-Cooper MJ, Paiva M, et al: Fibrinogen stabilizes placental-maternal
tors contributing to fibrin-dependent plasminogen activation. Thromb Haemost 79:796, attachment during embryonic development in the mouse. Am J Pathol 160:1021, 2002.
1998. 60. Korte W, Feldges A: Increased prothrombin activation in a patient with congenital
30. Medved L, Niewenhuizen W: Molecular mechanisms of initiation of fibrinolysis by afibrinogenemia is reversible by fibrinogen substitution. Clin Investig 72:396, 1994.
fibrin. Thromb Haemost 89:409, 2003. 61. Ni H, Denis CV, Subbarao S, et al: Persistence of platelet thrombus formation in arte-
31. Rijken DC, Lijnen HR: New insights into the molecular mechanisms of the fibrinolytic rioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106:385,
system. J Thromb Haemost 7:4, 2009. 2000.
32. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, et al: Genetic variation in 62. Fish RJ, Di Sanza C, Neerman-Arbez M. Targeted mutation of zebrafish FGA models
the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing human congenital afibrinogenemia. Blood 123:2278, 2014.
plasma fibrinogen gamma′ levels. Blood 106:4176, 2005. 63. Remjin JA, Wu Y-P, Ijsseldijk W, et al: Absence of fibrinogen in afibrinogenemia results
33. Fredenburgh JC, Stafford AR, Leslie BA, Weitz JI: Bivalent binding to to gammaA/ in large but loosely packed thrombi under flow conditions. Thromb Haemost 85:736,
gamma′-fibrin engages both exosites of thrombin and protects it from inhibition by the 2001.
antithrombin-heparin complex. J Biol Chem 283:2470, 2008. 64. de Moerloose P, Neerman-Arbez M: Treatment of congenital fibrinogen disorders.
34. Blomback M, Blomback B, Mammen EF, Prasad AS: Fibrinogen Detroit—A molecular Expert Opin Biol Ther 8:979, 2008.
defect in the N-terminal disulphide knot of human fibrinogen? Nature 218:134, 1968. 65. Galanakis DK, Neerman-Arbez M, Scheiner T, et al: Homophenotypic A-alpha R16H
35. Neerman-Arbez M, Honsberger A, Antonarakis SE, Morris MA: Deletion of the fibrin- fibrinogen (Kingsport): Uniquely altered polymerization associated with slower
ogen alpha-chain gene (FGA) causes congenital afibrinogenemia. J Clin Invest 103:215, fibrinopeptide A than fibrinopeptide B release. Blood Coagul Fibrinolysis 18:731, 2007.
1999. 66. Neerman-Arbez M, Vu D, Abu-Libdeh B, et al: Prenatal diagnosis for congenital afi-
36. Rabe F, Salomon E: Ueber-faserstoffmangel im Blute bei einem Falle von Hämophilie. brinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian
Arch Intern Med 95:2, 1920. family. Blood 101:3492, 2003.
37. Peyvandi F, Mannucci PM: Rare coagulation disorders. Thromb Haemost 82:1207, 1999. 67. Kalina U, Stöhr HA, Bickhard H, et al: Rotational thromboelastography for monitoring
38. Watanabe K, Shibuya A, Ishii E, et al: Identification of simultaneous mutation of fibrino- of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis
gen alpha chain and protein C genes in a Japanese kindred. Br J Haematol 120:101, 2003. 19:777, 2008.
39. Spena S, Duga S, Asselta R, et al: Congenital afibrinogenaemia caused by uniparental 68. Bolton-Maggs PH, Perry DJ, Chalmers EA, et al: The rare coagulation disorders—
isodisomy of chromosome 4 containing a novel 15-kb deletion involving fibrinogen Review with guidelines for management from the United Haemophilia Centre Doctor’s
Aalpha-chain gene. Eur J Hum Genet 12:891, 2004. Organisation. Haemophilia 10:593, 2004.
40. Monaldini L, Asselta R, Duga S, et al: Mutational screening of six afibrinogenemic 69. Grech H, Majumdar G, Lawrie AS, Savidge GF: Pregnancy in congenital afibrinoge-
patients: Identification and characterization of four novel molecular defects. Thromb naemia: Report of a successful case and review of the literature. Br J Haematol 78:571,
Haemost 97:546, 2007. 1991.
41. Neerman-Arbez M, de Moerloose P: Mutations in the fibrinogen gene cluster account- 70. Kobayashi T, Kanayama N, Tokunaga N, et al: Prenatal and peripartum management of
ing for congenital afibrinogenemia: An update and report of 10 novel mutations. Hum congenital afibrinogenaemia. Br J Haematol 109:364, 2000.
Mutat 28:540, 2006. 71. Fuchs RJ, Levin J, Tadel M, Merritt W: Perioperative coagulation management in a
42. Robert-Ebadi H, de Moerloose P, El Khorassani M, et al: A novel frameshift mutation patient with afibrinogenemia undergoing liver transplantation. Liver Transpl 13:752,
in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant 2007.
peptide terminating 158 amino acids downstream. Blood Coagul Fibrinolysis 20:385, 72. Stroka D, Keogh A, Vu D et al: In vitro rescue of FGA deletion by lentiviral transduction
2009. of afibrinogenemic patient’s hepatocytes. J Thromb Haemost 12:1874, 2014.

Kaushansky_chapter 125_p2151-2162.indd 2160 9/18/15 5:48 PM